MedTrace Logo

The TERUMO FRED X EARLY FEASIBILITY STUDY (FAST) STUDY.

NCT07761598 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2026-08-12

No results posted yet for this study

Summary

The TERUMO FRED X EARLY FEASIBILITY STUDY (FAST) is a prospective, single-arm investigation.

Conditions

  • Aneurysm Cerebral

Interventions

DEVICE

Fred X Medical Device Intervention for Aneurysm Treatment with DAPT Therapy.

medial device intervention for aneurysm cerebral.

Sponsors & Collaborators

  • University at Buffalo

    collaborator OTHER

  • Jacobs institute

    lead OTHER

Principal Investigators

  • Elad Dr. Levy, MD · Jacobs institute

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
22 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-08-31
Primary Completion
2028-12-31
Completion
2028-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07761598 on ClinicalTrials.gov